Company & Sponsor Intelligence
The University of Texas Health Science Center at San Antonio
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials8
Recruiting3
Completed5
Countries1
Therapeutic footprint
adhdalzheimerspain_neuropathyparkinsons
Indexed studies
NCT07356414SwallowFIT Study in Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT01069523Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
adhd · United StatesPHASE4
adhd · United StatesPHASE4
NCT06133283Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT04200911Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway
alzheimers · United StatesEARLY_PHASE1
alzheimers · United StatesEARLY_PHASE1
NCT05592678δ in Dementia Clinical Trials
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT04680000Chronic Pain Management In Primary Care Using Behavioral Health Consultants
pain_neuropathy · United StatesNA
pain_neuropathy · United StatesNA
NCT04063124Senolytic Therapy to Modulate Progression of Alzheimer's Disease
alzheimers · United StatesPHASE1, PHASE2
alzheimers · United StatesPHASE1, PHASE2
NCT00778310Neuroimaging of the Effects of Concerta in the Treatment of ADHD
adhd · United StatesPHASE4
adhd · United StatesPHASE4
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →